Graph not available
Graph not available

Open Demat Account

50years
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O
left-arrow
Fundamentals
Financials
Shareholding
Resistance/Support
Delivery and Volume
About
Management
News
Similar Stocks
right-arrow

Phaarmasia Ltd Fundamentals

Market Cap
₹ 25.61 Cr
P/E Ratio (TTM)
0.00
P/B Ratio
4.17
Debt to Equity
0.02
ROE
0.00
EPS (TTM)
0.00
Dividend Yield
0.00 %
Book Value
9.00

Click here to know more about Fundamentals

Phaarmasia Ltd Financials

Phaarmasia Ltd Financials

Phaarmasia Ltd Shareholding Pattern

Held By Mar 2024 Dec 2023 Sep 2023 Jun 2023
Promoters 73.51 % 73.51 % 73.51 % 73.51 %
Retail 26.17 % 26.16 % 26.20 % 26.25 %
Others 0.32 % 0.33 % 0.29 % 0.24 %
Mutual Funds 0.00 % 0.00 % 0.00 % 0.00 %
FII 0.00 % 0.00 % 0.00 % 0.00 %

Promoters

73.51%

Retail

26.17%

Others

0.32%

Mutual Funds

0.00%

FII

0.00%

Promoters

73.51%

Retail

26.16%

Others

0.33%

Mutual Funds

0.00%

FII

0.00%

Promoters

73.51%

Retail

26.20%

Others

0.29%

Mutual Funds

0.00%

FII

0.00%

Promoters

73.51%

Retail

26.25%

Others

0.24%

Mutual Funds

0.00%

FII

0.00%

Resistance and Support

₹37.50

PIVOT

resistance-arrow
Resistance
First Resistance₹37.500
Second Resistance₹37.500
Third Resistance₹37.500
support-arrow
Support
First Support₹37.500
Second Support₹37.500
Third Support₹37.500

Delivery and Volume

PeriodDelivery Volume Traded Volume Delivery Volume %
Day275275100.00
Week2758820.00
1 Month2753,7160.00
6 Months295,239244,93490.39

About Phaarmasia Ltd

Incorporated in 1981, Phaarmasia Limited (unit-I) is the part of the Maneesh Pharmaceutical Limited, with its headquarters and marketing office in Mumbai. M/s Phaarmasia Limited Unit-II was established in 1993-94. The Company is engaged in manufacturing and marketing of Oral contraceptive tablets' with various therapeutic dosage combinations along with iron tablets for Ministry of Health & Family Welfare and for Exports. The plant is situated in a hygienic environment; free from dust, smoke, chemical & biological emission. Phaarmasia Ltd. Is an independent State-of-the-art-manufacturing unit having manufacturing facility of international standards with manufacturing capacity of more than 30 million units per annum. During the year 2000, the company became a Sick Industrial Company under SICA and therefore the same was referred to the BIFR. During past a few decades, Phaarmasia mastered and manufactured wide range of Pharmaceutical Formulations at a WHO-GMP certified and ISO 9001-certified manufacturing facility.

Managing Director

1981

Founded

NA

NSE Symbol

NA

Phaarmasia Ltd Management

NameDesignation
Vinay Ramakant SapteNon Executive Director
Maneesh R SapteNon Executive Director
Y N Bhaskara RaoWhole-time Director
Rashmi V SapteNon Executive Director
PRAVIN M. HEGDEIndependent Director
Ajit G JamkhandikarIndependent Director
Urvashi BhatiaCompany Sec. & Compli. Officer

Phaarmasia Ltd News

Phaarmasia to announce Quarterly Result
On 25 May 2024
Phaarmasia reports standalone net loss of Rs 0.56 crore in the December 2023 quarter
Sales decline 36.02% to Rs 5.08 crore
Phaarmasia to conduct board meeting
On 13 February 2024
Phaarmasia reports standalone net loss of Rs 0.16 crore in the September 2023 quarter
Sales rise 29.54% to Rs 8.64 crore
Phaarmasia announces board meeting date
On 14 November 2023
Phaarmasia reports standalone net loss of Rs 0.27 crore in the June 2023 quarter
Sales rise 27.88% to Rs 6.88 crore
Phaarmasia to declare Quarterly Result
On 14 August 2023
Phaarmasia schedules AGM
On 10 July 2023
Phaarmasia schedules AGM
On 10 July 2023
Phaarmasia to conduct board meeting
On 13 June 2023

Similar Stocks

CompanyMarket CapMarket PriceP/E Ratio
Sun Pharmaceuticals Industries Ltd₹ 367554.12 Cr
₹ 1,531.90
(0.03 %)
89.16
Cipla Ltd₹ 113362.29 Cr
₹ 1,404.05
(0.36 %)
30.52
Zydus Lifesciences Ltd₹ 111083.2 Cr
₹ 1,103.95
(5.00 %)
41.35
Divis Laboratories Ltd₹ 104302.61 Cr
₹ 3,929.00
(0.47 %)
76.42
Dr Reddys Laboratories Ltd₹ 96948.1 Cr
₹ 5,811.60
(0.21 %)
22.34

Phaarmasia Ltd FAQ

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Phaarmasia Ltd shares in BlinkX

Phaarmasia Ltd's P/E ratio is 0.00 times as of May 17, 2024 at 04:00 PM.

Phaarmasia Ltd's most recent financial reports indicate a price-to-book ratio of 4.17, showing the company's stock market valuation in relation to the value of its real assets.

Market capitalisation, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Phaarmasia Ltd's market is 26 Cr as on May 17, 2024 at 04:00 PM.

The current financial records of Phaarmasia Ltd show a 0.00% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.

According to Phaarmasia Ltd's most recent financial filings, the company has a total asset value of Crores, which includes current and non-current assets such as inventory, cash, properties, and equipment.

As of the Mar 2024 quarter, the promoter shareholding in Phaarmasia Ltd stands at 73.51%. During the same period, Institutional Investors have shown a slight values are equal in their holdings, values are equal from 0.00% to 0.00%.